{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:15:06Z","timestamp":1778652906644,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical adenocarcinoma is an increasingly common and aggressive subtype of cervical cancer with marked biological heterogeneity. Accumulating evidence suggests that HPV-positive and HPV-negative adenocarcinomas exhibit distinct immune microenvironments, but the underlying mechanisms remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Publicly available single-cell RNA sequencing datasets of cervical adenocarcinoma and normal cervical tissues were systematically analyzed using integrated bioinformatic approaches, including cell clustering, copy number variation inference, metabolic pathway analysis, and cell\u2013cell communication modeling. Key findings were validated through\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments using cervical cancer cell lines, macrophage polarization assays, metabolic measurements, ELISA, immunofluorescence, and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell functional analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Single-cell analysis revealed profound differences in cellular composition and immune states between HPV-negative and HPV-positive adenocarcinomas. HPV-negative tumors exhibited increased immune infiltration but were enriched for exhausted CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells and immunosuppressive SPP1\n                      <jats:sup>+<\/jats:sup>\n                      macrophages. Malignant epithelial cells from HPV-negative adenocarcinoma displayed distinct metabolic reprogramming characterized by activation of cholesterol biosynthesis pathways, elevated DHCR7 expression, and accumulation of the oxysterol 27-hydroxycholesterol (27-HC). Functionally, 27-HC induced macrophage polarization toward an immunosuppressive phenotype and promoted SPP1 secretion. Macrophage-derived SPP1, in turn, enhanced DHCR7 expression and 27-HC production in tumor cells via CD44, forming a positive feedback loop that reinforced immune suppression. Disruption of DHCR7 attenuated macrophage-mediated immunosuppression and alleviated CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell exhaustion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies a DHCR7\u201327-HC\u2013SPP1 metabolic\u2013immune axis that drives immune escape in HPV-negative cervical adenocarcinoma, highlighting cholesterol metabolism as a potential therapeutic vulnerability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1808107","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:56:28Z","timestamp":1778651788000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Jianing","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gynecology, Dalian Women and Children\u2019s Medical Group","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Central Laboratory, Dalian Women and Children\u2019s Medical Group","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Dalian Women and Children\u2019s Medical Group","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Liaoning Provincial Key Laboratory, Dalian Women and Children\u2019s Medical Group","place":["Dalian, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: Population-based global epidemiological profiling","volume":"9","author":"Zhang","year":"2023","journal-title":"JMIR Public Health Surveillance"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-024-01254-9","article-title":"Contemporary review of adenocarcinoma of the cervix","volume":"25","author":"Desravines","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/pap.0000000000000411","article-title":"Invasive squamous cell carcinoma of the cervix: A review of morphological appearances encountered in human papillomavirus-associated and papillomavirus-independent tumors and precursor lesions","volume":"31","author":"Stolnicu","year":"2024","journal-title":"Adv Anatomic Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.55","article-title":"HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases","volume":"27","author":"Pirog","year":"2014","journal-title":"Modern Pathology: Off J United States Can Acad Pathology Inc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-025-02256-3","article-title":"Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers","volume":"24","author":"Hyeon","year":"2025","journal-title":"Mol Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/v17040515","article-title":"Papillomavirus-induced oncogenesis: Bridging molecular mechanisms, diagnostics, and global prevention strategies","volume":"17","author":"Ashrafi","year":"2025","journal-title":"Viruses"},{"key":"B8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12967-025-06470-x","article-title":"Human papilloma virus (HPV) mediated cancers: An insightful update","volume":"23","author":"Baba","year":"2025","journal-title":"J Transl Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0000000000001095","article-title":"International Endocervical Adenocarcinoma Criteria and Classification (IECC): A new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/js9.0000000000001997","article-title":"Treatment patterns and prognosis of patients with clear cell adenocarcinoma of the cervix: A population-based cohort study","volume":"111","author":"Li","year":"2025","journal-title":"Int J Surg (London England)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315022","article-title":"HPV-negative adenocarcinomas of the uterine cervix: From molecular characterization to clinical implications","volume":"23","author":"Giannella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: Results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2023.200258","article-title":"Human papillomavirus genomics: Understanding carcinogenicity","volume":"15","author":"Nelson","year":"2023","journal-title":"Tumour Virus Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070115","article-title":"Human papillomavirus vaccination and cervical cancer risk","volume":"379","author":"Rahangdale","year":"2022","journal-title":"BMJ (Clinical Res Ed)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12032-022-01854-1","article-title":"Investigation of molecular mechanisms underlying JAK\/STAT signaling pathway in HPV-induced cervical carcinogenesis using \u2018omics\u2019 approach","volume":"39","author":"Thakur","year":"2022","journal-title":"Med Oncol (Northwood London England)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7150\/thno.84710","article-title":"Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg3868","article-title":"Cellular and molecular waypoints along the path of T cell exhaustion","volume":"8","author":"Lan","year":"2023","journal-title":"Sci Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: An accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J BioMed Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.70065","article-title":"Tumor immune contexture model predicts prognosis and immunotherapy response in gastric cancer","volume":"27","author":"Wang","year":"2025","journal-title":"J Gene Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107161","article-title":"Molecular insight into T cell exhaustion in hepatocellular carcinoma","volume":"203","author":"Zhu","year":"2024","journal-title":"Pharmacol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2024.200302","article-title":"Fibroblasts regulate the transcriptional signature of human papillomavirus-positive keratinocytes","volume":"19","author":"James","year":"2025","journal-title":"Tumour Virus Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-023-02337-7","article-title":"Carcinogenesis and management of human papillomavirus-associated cervical cancer","volume":"28","author":"Kusakabe","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2021.12.012","article-title":"Metabolic adaptation of lymphocytes in immunity and disease","volume":"55","author":"Chapman","year":"2022","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nature07202","article-title":"Integration of metabolism and inflammation by lipid-activated nuclear receptors","volume":"454","author":"Bensinger","year":"2008","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.639757","article-title":"Disrupted lipid metabolism in multiple sclerosis: A role for liver X receptors","volume":"12","author":"Pineda-Torra","year":"2021","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1038\/s41467-023-39586-z","article-title":"Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice","volume":"14","author":"Yu","year":"2023","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Sci (New York NY)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.cd-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): A randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet (London England)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:56:29Z","timestamp":1778651789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2026.1808107"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1808107","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1808107"}}